Literatur
Anderson, D. L.: Electron microscopic observations of the structure of Mycoplasma laidlawii. Electron Microscopic Proc. European regional Conf., 3rd, Prague, 1964, 539–540.
Anderson, D. R., andM. F. Barile: Ultrastructure of Mycoplasma hominis. J. Bacteriol.90, 180–192 (1965).
-- -- Ultrastructure of Mycoplasma orale isolated from patients with leucaemia. J. Nat. Cancer Inst. 1965, 161–167.
——, andBarbara C. Bernheim: Comparison of the ultrastructure of several Rickettsiae, Ornithosis virus and Mycoplasma in tissue culture. J. Bacteriol.90, 1387–1404 (1965).
Baernstein jr., H. D., E. Trevisani, Shirley Axtell, andJ. J. Quilligan, Jr.: Mycoplasma pneumoniae (Eaton atypical pncumonia agent) in children's respiratory infections. J. Pediatrics66, 829–837 (1965).
Bakos, K., A. Bane andE. Thal: Mycoplasmen (PPLO) in Beziehung zur Fruchtbarkeit bei Bullen. Zbl. Vet. Med.9, 397–410 (1962).
Barile, M. F., G. P. Bodey, J. Snyder, D. B. Riggs, andMarion W. Grabowski: Isolation of Mycoplasma orale from leucaemic bone marrow and blood by direct culture. J. Nat. Cancer Inst.1966, 155.
--W. F. Malizia, andD. B. Riggs: Immunofluorescence of PPLO in tissue cultures. Bacteriol. Proc.1961, 83.
—— —— —— Incidence and detection of pleuropneumonia-like organisms in cell cultural procedures. J. Bacteriol.84, 130–136 (1962).
——, andR. T. Schimke: A rapid chemical method for detecting PPLO contamination of tissue cell cultures. Proc. Soc. exp. Biol. Med.114, 676–679 (1963).
—— ——, andD. B. Riggs: Presence of the arginine Dihydrolase pathway in Mycoplasma. J. Bacteriol.91, 189–192 (1966).
Bartmann, K., u.W. Höpken: Zur Heteromorphie der Bakterien. Bildatlas pathogener Mikroorganismen.G. Henneberg. Stuttgart: Gustav Fischer 1963.
Bassermann, Fr. J.: Die L-Form des Tuberkuloseerregers in elektronenoptischer Darstellung. Beitr. Klin. Tuberk.113, 134–145 (1955).
—— Die nachgehende diagnostische Klärung flüchtiger Lungeninfiltrate. Tuberk.-Arzt16, 424–434 (1962).
Bassermann, Fr. J.: Flüchtige unspezifische Lungeninfiltrate; Viruspneumonien. Beitr. Klin. Tuberk.132, 165–177 (1965).
—— Vorkommen und Bedeutung von Mycoplasmataceen (PPLO) im menschlichen Atemtrakt. Prax. Pneumol.20, 317–324 (1966).
—— Virogene Infektionen der Atemwege. Dtsch. med. Wschr.91, 1887–1889 (1966).
Beller, K.: Infektiöse Agalaktie der Ziegen und der Schafe. In: Hdb. d. Viruskrankheiten, 2. Bd. Jena: Gustav Fischer 1939.
Bergey's Manual of Determinative Bacteriology. Edited byBreed, R. S., E. G. D. Murray, andN. R. Smitii: Baltimore: The Williams and Wilkins Co. 1957.
Bögel, K., M. Berchthold, M. A. Brunner u.L. Klinger: Die Eignung der Gewebekulturtechnik zur Isolierung und Charakterisierung eines zytopathogenen Mycoplasmastammes von Bullen. Zbl. Bakteriol. I. Orig.185, 423–439 (1952).
Borgno, M.: Unspezifische Urethriden. Münch. med. Wschr.107, 2645–2648 (1965).
Brenner, S., andR. Horne: A negative staining method for high resolution electron microscopy of viruses. Biochem. Biophys. Acta34, 103–110 (1959).
Bridé, J., etA. Donatien: Le microbe de l'agalaxie contagieuse des chèvres et sa culture in vitro. C. r. Acad. Sci.177, 841 (1923).
—— —— Le microbe l'agalaxie contagieuse du mouton et de la chèvre. Ann. Inst. Pasteur39, 925 (1925).
Carski, R. C., andCh. C. Shepard: Pleuropneumonia-like (Mycoplasma) infections of tissue culture. J. Bacteriol.81, 626–635 (1961).
Chalquest, R. R.: Cultivation of the infectious synovitis-type pleuropneumonia-like organisms. Avian Dis.6, 36–43 (1962).
——, andJ. Fabricant: Pleuropneumonia-like organisms associated with synovitis in fowls. Avian Dis.4, 515–539 (1960).
Chanock, R. M.: Mycoplasma pneumoniae. Proposed nomenclature for atypical Pneumonia organisms (Eaton agent). Science140, 662 (1963).
—— andR. J. Huebner: Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood. New Engl. J. Med.262, 648–654 (1960).
——, andM. F. Barile: Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc. Nat. Acad. Sci.48, 41–49 (1962).
——, andJ. R. Kingston: Eaton agent pneumonia, I. Ecology of infection in an military recruit population. J. Amer. med. Ass.175, 213–220 (1961).
—— ——, andR. B. Cough: Role of mycoplasma (PPLO) in human respiratory disease. Amer. Rev. resp. Dis.88, 218 (1962).
——, andK. M. Johnson: Respiratory disease in volunteers infected with Eaton agent. Prod. Nat. Acad. Sci.47, 887–890 (1961).
Clyde, W. A.: Demonstration of Eaton's agent in tissue culture. Proc. Soc. exp. Biol. Med.107, 715–718 (1961).
—— Hemolysis in identifying Eaton's pleuropneumonialike organisms. Science139, 55 (1963).
—— Mycoplasma species identification based upon growth inhibition by specific antisera. J. Immunol.92, 958–965 (1964).
Collier, L. H.: Contamination of stock lines of human carcinoma cells by pleuropneumonia-like organisms. Nature180, 757–758 (1957).
Cook, M. K., R. M. Chanock, H. H. Fox, E. L. Buescher, R. T. Johnson, andR. J. Huebner: Studies on the role of Eaton agent in lower respiratory tract illness. Evidence for infection in adults. Brit. med. J.1, 905–911 (1960).
Dacie, J. V.: The hemolytic anaemias, 2rd. Ed. New York: Grune & Stratton 1962, p. 342–494.
Dannis, C. Dorothy, andJ. H. Marston: Fine structure of staphylococcal L-forms. Texas Rep. Biol. Med.23, 729–736 (1965).
Dienes, L.: Electron micrographs made from L-forms of Proteus and two human strains of Pleuropneumonia-like Organisms. J. Bacteriol.66, 280–283 (1953).
Djkman, J. H.: Onderzoek over het voorkomen en de oorzaken van logafurigkingen biy militairen met akute luchtweginfekties. Proefschrift Nijmegen 1963.
Domermuth, C. H., M. H. Nielsen, E. A. Freundt, andA. Birch-Anderson: Ultrastructure of mycoplasma species. J. Bacteriol.88, 727–744 (1964).
Eaton, M. D., G. Meiklejohn, andW. van Herick: Studies on etiology of primary atypical pneumonia: I. Filtrable agent transmissable to cotton rats, hamsters, and chick embryos. J. exp. Med.79, 649–668 (1944).
Edwards, G. A., andJ. Fogh: Fine structure of pleuropneumonia-like organisms in pure culture and in infected tissue culture cells. J. Bacteriol.79, 267–276 (1960).
Fleming, A.: On an remarkable bacteriolytic element found in tissues and secretions. Proc. Roy. Soc.93, 306 (1922).
Freundt, E. A.: The classification of the pleuropneumonia group of organisms Boreliomycetales. Intern. Bull. Bact. Nomencl. Taxon.15, 67 (1955).
—— Morphology and classification of PPLO. Ann. N.Y. Acad. Sci.79, 312–325 (1960).
Fogh, J., andHelle Fogh: A method for direct demonstration of pleuropneumonia-like organisms in cultured cells. Proc. Soc. Exper. Biol. Med.117, 899–901 (1964).
—— —— Chromosome changes in PPLO-infected FL-human amnion cell. Proc. Soc. exp. Biol. Med.119, 233–238 (1965).
——, andHelle Fogh: Effects of pleuropneumonia-like organisms on cultured cells. Exp. Cell Research39, 554–566 (1965).
Girardi, A. J., V. V. Hamparian, N. L. Somerson, andL. Hayflick: Mycoplasma isolates from primary cell cultures and human diploid cell strains. Proc. Soc. exp. Biol. Med.120, 760–771 (1965).
——, andN. L. Somerson: Recovery of mycoplasmas in the study of human leucaemia and other malignancies. Nature205, 188–189 (1965).
Gori, G. B., andDoo Young Lee: A method for eradication of mycoplasma infections in cell cultures. Proc. Soc. exp. Biol. Med.117, 918–921 (1964).
Griffin, J. P., andJ. E. Crawford: Mycoplasma pneumoniae in primary atypical pneumonia. J. Amer. med. Ass.193, 1011–1016 (1965).
Grist, N. R., andR. F. Fallon: Isolation of viruses from leukaemic patients. Brit. med. J.2, 1263 (1964).
Hartwich, J., u.U. Müller: Zur Isolierung von Schweinemycoplasmen mit Hilfe des Eitestes und der Plattenkultur. Zbl. Bakter. I. Orig.197, 532–543 (1965).
Hayflick, L., andH. Koprowski: Direct agar isolation of mycoplasmas from human leukaemie bone marrow. Nature205, 713–714 (1965).
Hearn, H. J., Jr., J. E. Officer, Virginia Elsner, andA. Brown: Detection, elimination and prevention of contamination of cell cultures with pleuropneumonia-like organisms. J. Bacteriol.78, 575–582 (1959).
Herderschee, D., A. C. Ruys, andG. R. van Rhijn: A new oral mycoplasma isolated from the tonsils of two patients suffering from scarlatina. Antonie Leeuwenhoek29, 157–162 (1963).
Herzberg, K., u.W. Gross: Untersuchungen über Influenza. III. Mitt. Darstellung des filtrierbaren Pneumonieerregers durch den Mäuseversuch. Zbl. Bakter., I. Orig.146, 129–139 (1941).
Holmgren, N. B., andW. E. Campbell, Jr.: Tissue cell culture contamination in relation to bacterial pleuropneumonia-like organisms-L form conversion. J. Bacteriol.79, 869–874 (1960).
--, andN. H. Smith: The effect of ultraviolett irradiation on PPLO in experimentally infected serum and on the imunitional quality of serum. Bacteriol. Proc. 1959, 58.
Inman, R., D. A. Woods, andG. Negroni: Electron microscopy of virus particles in cell cultures inoculated with passage fluid from human leukaemic bone marrow. Brit. med. J.1, 927–929 (1964).
Jansson, E. O., O. Wager, R. Stenström, E. Klemola, andP. Forsell: Studies on Eaton PPLO pneumonia. Brit. med. J.1, 142–145 (1964).
Jensen, K. E., L. B. Senterfit, R. M. Chanock, C. B. Smith, andR. H. Purcell: An inactivated mycoplasma pneumoniae Vaccine. J. Amer. med. Ass.194, 248–252 (1965).
Johnson, R. T., M. K. Cook, R. M. Chanock, andE. L. Buescher: Family outbreak of primary atypical pneumonia associated with Eaton agent. New Engl. J. Med.262, 817–819 (1960).
Kim, K. S., W. R. Bibb, W. A. Clyde, Jr., andF. W. Denny: A new mycoplasma species from the human pharynx: Physical properties. Bacteriol. Proc., 1965, 56.
Klieneberger-Nobel, E.: Pleuropneumonia-like organisms (PPLO)-Mycoplasmataceae. London and New York: Acedemic Press 1962.
Klinge, K.: Über einen vom Chamäleon isolierten pleuropneumonieähnlichen Mikroorganismus (PPLO). Arch. Hyg. Bakteriol.138, 332–344 (1954).
Köhler, W.: Die pleuropneumonie-ähnlichen Mikroorganismen (PPLO). Zbl. Bakter., II Ref.175, 305–320 (1960).
—— Das Verhalten eines aviären und eines humanen PPLO-Stammes in virusinfizierten und ascitestumortragenden Mäusen. Z. Bakter., I. Orig.185, 243–251 (1962).
—— Antibiotikaempfindlichkeit humaner PPLO-Stämme. Zbl. Bakter., I. Orig.185, 355 bis 366 (1962).
Kraemer, P. M.: Mycoplasma (PPLO) from covertly contaminated tissue cultures: Differences in Arginine degradation between strains. Proc. Soc. exp. Biol. Med.117, 910–918 (1964).
Krech, U.: Die Bedeutung der Mykoplasmen in der Humanmedizin. Schweiz. med. Wschr.95, 1635–1640 (1965).
——, u.H. Modde: Untersuchungen über Häufigkeit und Bedeutung von Infektionen mit Mycoplasma pneumoniae. Dtsch. med. Wschr.91, 1013–1015 (1966).
Krücken, H., u.H. Fabry: Pleuropneumonia-like organisms bei Morbus Reiter und verwandten Syndromen. Ärztl. Wschr.10, 294 (1955).
Lecce, J. G.: Porcine polyserositis with arthritis isolation of a fastidious pleuropneumonia-like organisms and Haemophilus influenzae-suis. Ann. N. Y. Acad. Sci.79, 670–676 (1960).
Lederberg, J., andSt. Clair, J.: Protoplasts and L-Type growth. of E. Coli. J. Bacteriol.75, 143–147 (1958).
Lundblad, G., andE. Hultin: Human serum lysozyme (Muramidase). Scand. J. Clin. Laborat. Invest.18, 201–208 (1966).
Lwoff, A., andM. Lwoff: Studies on codehydrogenases: nature of growth factor „V“. Proc. Roy. Soc. (London)122, 253–259 (1937).
Maliza, W. F., M. F. Barile, andD. B. Riggs: Immunofluorescence of pleuropneumonia-like organisms isolated from tissue cell culture. Nature191, 190–191 (1961).
Mooser, H.: Über die Mischinfektion der weißen Maus mit einem Stamm klassischen Fleckfiebers und dem Virus der infektiösen Ektromelie. Schweiz. Z. Path. Bakter.6, 463–473 (1943).
——, u.N. Joos: Die Infektion der Maus mit menschlichen PPLO-Stämmen. Schweiz. Z. Path. Bakter.15, 735–740 (1952).
Morton, H. E., P. F. Smith, andP. R. Lebermann: Symbiotic growth of pleuropneumonia-like organisms with bacterial colonies. Proc. Soc. exp. Biol. Med.72, 328–330 (1949).
Murphy, W. H., D. Furtado, andE. Plata: Possible association between leukaemia in children and virus-like agents. J. Amer. med. Assoc.191, 110–115 (1965).
Nasemann, Th., H. Röckl u.O. Huber: Die pleuropneumonie-ähnlichen Organismen. Verhalten in der Eikultur und im Resistenzversuch. Klin. Wschr.32, 717–721 (1954).
Negroni, G.: Isolations of viruses from leukaemic patients. Brit. med. J.1, 927–929 (1964).
Nocard, E., etE. R. Roux, avec la collaboration deMm. Borrel, Salimbeniet etDujardin-Beometz: Le microbe de la péripneumonie. Ann. Inst. Pasteur12, 240 (1898).
Nowak, J.: Morphologie, nature et cycle evolutiv du microbe de la péripneumonie des bovidés. Ann. Inst. Pasteur43, 1330 (1929).
Porter, G. H., A. J. Dalton, J. B. Moloney, andE. Z. Mitchell: Association of electron-dense particles with human acute leukaemia. J. Nat. Cancer Inst.33, 547–556 (1964).
Prittwitz u.Gaffron, Jutta von: Fehlerquellen bei der Begutachtung von Kulturen und mikroskopischen Präparaten pleuropneumonieähnlicher Organismen. Naturwiss.42, 113–115 (1955).
Randall, Ch. C., Lanelle G. Gafford, G. A. Gentry, andL. A. Lwason: Lability of host-cell-DNA in growing cell cultures due to mycoplasma. Science149, 1098–1099 (1965).
Robinson, L. B., R. H. Wichelhausen, andT. Mc P. Brown: Sensitivity studies on human pleuropneumonia-like organisms. J. Lab. clin. Med.39, 290–302 (1952).
—— ——, andB. Roizman: Contamination of human cell cultures by pleuropneumonia-like organisms. Science124, 1147–1148 (1956).
Röckl, H., Th. Nasemann u.E. Stettwieser: Untersuchungen zur Pathogenität der Pleuropneumonieähnlichen Organismen im Urogenitaltrakt des Menschen mit besonderer Berücksichtigung der unspezifischen Urethritis. Hautarzt5, 340–348 (1954).
Rothblat, G. H., andH. E. Morton: Detection and possible source of contaminatly pleuropneumonia-like organisms (PPLO) in culture of tissue cells. Proc. Soc. Expl. Biol. Med.100, 87–90 (1959).
Ruska, H., u.K. Poppe: Elektronenmikroskopische Untersuchungen zur Morphologie der Seiffertschen Mikroorganismen und des Erregers der Lungenseuche des Rindes. Z. Hyg.127, 201–215 (1947).
Salton, M. R. J., andJ. M. Ghuysen: Acetylhexosamine compounds anzymically released from Micrococcus lysodeicticus cell walls. Biochem. biophys. Acta.45, 355 (1960).
Schimke, R. T., andM. F. Barile: Arginine metabolism in pleuropneumonia-like organisms isolated from mammalian cell culture. J. Bacteriol.86, 195–206 (1963).
—— —— Arginine breakdown in mammalian cell culture contaminated with pleuropneumonia-like organisms (PPLO). Exper. Cell Research30, 593–596 (1963).
Schmidt, P. J., M. F. Barile, andMary H. McGinniss: Mycoplasma (Pleuropneumonia-like organisms) and blood group I; associations with neoplastic disease. Nature205, 371–372 (1965).
Smith, W. E., J. Hillier, andSt. Mudd: Electron micrograph studies of two strains of pleuropneumonia-like (L) organisms of human derivation. J. Bacteriol.56, 589 bis 601 (1948).
Speck, J.: Vorkommen und Bedeutung von Mycoplasma laidlawi und Mycoplasma bovigenitalium im Genitaltrakt des Rindes. Monatsh. Tierhk.14, 244–256 (1962).
Sterner, G., G. de Heves, G. Tunevall, andS. Wolontis: An outbreak of mycoplasma pneumoniae in a home for children. Acta paed. (Uppsala), zit. nach 106.
——, andS. Wolontis: Infections with Eaton Agent in pneumonia. Acta Med. Scand.178, 751–757 (1965).
Stolp, H., andM. P. Starr: Bacteriolysis. Ann. Rev. Microbiol.19, 79–104 (1965).
Taylor-Robinson, D., J. Canchola, H. Fox, andR. M. Chanock: A newly identified oral Mycoplasma (M. orale) and its relationship to other human mycoplasmas. Amer. J. Hyg.80, 135–148 (1964).
Thacore, H., andHilda P. Willett: Formation of spheroplasts of Mycobacterium tuberculosis by lysozyme treatment. Proc. Soc. exp. Biol. Med.114, 43–47 (1963).
Iterson, W. van, andA. G. Ruys: On the nature of PPLO. II. Electron mycroscopy. Antonie van Leeuwenhoek. J. Microbiol. Serol.26, 9–22 (1960b).
Welshimer, H. J.: The action of lysozyme on the cell wall and capsule of bacillus megaterium. J. Bacteriol.66, 112–117 (1953).
Witzleb, W., M. Sprössig, G. Anger u.S. Heidler: Erkrankungen des Respirationstraktes durch Mycoplasma pneumoniae. Dtsch. med. Wschr.91, 429–433 (1966).
Zwick, W. inE. Gildemeister, E. Haagen, O. Waldmann: Lungenseuche des Rindes, Pleuropneumonia bovum contagiosa. Hdb. d. Viruskrankheiten. 2. Bd. Jena: Gustav Fischer 1939.
Author information
Authors and Affiliations
Additional information
Es werden 33 Bilder als Diapositive demonstriert, von denen nur 10 ausgewählte Darstellungen veröffentlicht werden. Auf die Zusammenstellung der Legenden wird verwiesen. Auch an dieser Stelle sei Herrn Dr.Jørgen Fogh vom Sloan Kettering Institute for Cancer Research, Boston, USA (Abb. 14, 15, 18, 19) sowie Herrn Dr.Michael F. Barile vom Department of Health, Education, and Welfare, Bethesda, Md., USA (Abb. 17, 20–27) für die großzügige Überlassung von Bildmaterial eigener Arbeiten herzlich gedankt.
Rights and permissions
About this article
Cite this article
Bassermann, F.J. Die Mycoplasmen (PPL-Organismen und ihre klinische Bedeutung). Beitr. Klin. Tuberk. 136, 73–99 (1967). https://doi.org/10.1007/BF02090262
Issue Date:
DOI: https://doi.org/10.1007/BF02090262